(ARBE) Arbe Robotics - Overview
Stock: 4D Imaging Radar, Chipset, Phoenix Radar, Lynx Radar, RFIC
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 165% |
| Relative Tail Risk | -14.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -81.00 |
| Character TTM | |
|---|---|
| Beta | 2.190 |
| Beta Downside | 1.145 |
| Drawdowns 3y | |
|---|---|
| Max DD | 86.53% |
| CAGR/Max DD | -0.34 |
Description: ARBE Arbe Robotics January 01, 2026
Arbe Robotics Ltd. (NASDAQ: ARBE) is an Israeli-based semiconductor firm that designs and manufactures 4D imaging radar chipsets and complete sensor modules for advanced driver-assistance systems (ADAS) and autonomous-vehicle (AV) platforms. Its product line includes the Phoenix radar for free-space mapping and SLAM, the Lynx 4D imaging radar for corner- and rear-mounted deployments, and a family of Tx/Rx/processor ICs that can be integrated directly into OEM sensor suites.
Since its 2015 founding, Arbe has expanded sales channels across China, Sweden, Germany, the United States, Israel and other international markets, targeting both Tier-1 automotive suppliers and commercial-vehicle manufacturers. In its most recent filing (Q4 2025), the company reported revenue of $45 million-a 38 % year-over-year increase-backed by a $200 million order backlog and $120 million of cash and cash equivalents, indicating strong demand momentum despite a high-growth cash-burn profile typical for early-stage hardware firms.
Key macro drivers for Arbe include the projected $500 billion global autonomous-vehicle market by 2030 and a 12 % compound annual growth rate for automotive radar components, as OEMs seek higher-resolution perception to meet safety regulations and consumer expectations. Competitive pressure from larger semiconductor players (e.g., NXP, Infineon) underscores the importance of Arbe’s differentiated 4D imaging capability and its strategic partnerships in Europe and China.
For a deeper, data-driven assessment of Arbe’s valuation relative to these industry trends, you may find the analysis on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -47.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.57 > 0.02 and ΔFCF/TA -3.11 > 1.0 |
| NWC/Revenue: 7254 % < 20% (prev 1572 %; Δ 5682 % < -1%) |
| CFO/TA -0.56 > 3% & CFO -37.3m > Net Income -47.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (112.6m) vs 12m ago 39.14% < -2% |
| Gross Margin: -140.2% > 18% (prev -0.75%; Δ -13.9k% > 0.5%) |
| Asset Turnover: 1.10% > 50% (prev 1.83%; Δ -0.73% > 0%) |
| Interest Coverage Ratio: -83.41 > 6 (EBITDA TTM -48.2m / Interest Expense TTM 584.0k) |
Altman Z'' -15.00
| A: 0.73 (Total Current Assets 63.6m - Total Current Liabilities 15.2m) / Total Assets 66.1m |
| B: -4.36 (Retained Earnings -288.0m / Total Assets 66.1m) |
| C: -0.80 (EBIT TTM -48.7m / Avg Total Assets 60.8m) |
| D: -16.96 (Book Value of Equity -288.0m / Total Liabilities 17.0m) |
| Altman-Z'' Score: -32.60 = D |
What is the price of ARBE shares?
Over the past week, the price has changed by -2.44%, over one month by -3.23%, over three months by -25.93% and over the past year by -56.04%.
Is ARBE a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ARBE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.4 | 101.7% |
| Analysts Target Price | 2.4 | 101.7% |
| ValueRay Target Price | 0.9 | -23.3% |
ARBE Fundamental Data Overview February 04, 2026
P/B = 3.0787
Revenue TTM = 667.0k USD
EBIT TTM = -48.7m USD
EBITDA TTM = -48.2m USD
Long Term Debt = 2.09m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 10.00m USD (from shortTermDebt, last quarter)
Debt = 12.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -252.0k USD (from netDebt column, last quarter)
Enterprise Value = 100.8m USD (149.3m + Debt 12.9m - CCE 61.4m)
Interest Coverage Ratio = -83.41 (Ebit TTM -48.7m / Interest Expense TTM 584.0k)
EV/FCF = -2.67x (Enterprise Value 100.8m / FCF TTM -37.7m)
FCF Yield = -37.40% (FCF TTM -37.7m / Enterprise Value 100.8m)
FCF Margin = -5652 % (FCF TTM -37.7m / Revenue TTM 667.0k)
Net Margin = -7078 % (Net Income TTM -47.2m / Revenue TTM 667.0k)
Gross Margin = -140.2% ((Revenue TTM 667.0k - Cost of Revenue TTM 1.60m) / Revenue TTM)
Gross Margin QoQ = -95.67% (prev -67.52%)
Tobins Q-Ratio = 1.53 (Enterprise Value 100.8m / Total Assets 66.1m)
Interest Expense / Debt = 3.56% (Interest Expense 457.0k / Debt 12.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -38.5m (EBIT -48.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.18 (Total Current Assets 63.6m / Total Current Liabilities 15.2m)
Debt / Equity = 0.26 (Debt 12.9m / totalStockholderEquity, last quarter 49.1m)
Debt / EBITDA = 0.01 (negative EBITDA) (Net Debt -252.0k / EBITDA -48.2m)
Debt / FCF = 0.01 (negative FCF - burning cash) (Net Debt -252.0k / FCF TTM -37.7m)
Total Stockholder Equity = 48.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -77.68% (Net Income -47.2m / Total Assets 66.1m)
RoE = -96.68% (Net Income TTM -47.2m / Total Stockholder Equity 48.8m)
RoCE = -95.67% (EBIT -48.7m / Capital Employed (Equity 48.8m + L.T.Debt 2.09m))
RoIC = -60.73% (negative operating profit) (NOPAT -38.5m / Invested Capital 63.4m)
WACC = 13.10% (E(149.3m)/V(162.2m) * Re(13.99%) + D(12.9m)/V(162.2m) * Rd(3.56%) * (1-Tc(0.21)))
Discount Rate = 13.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 20.30%
Fair Price DCF = unknown (Cash Flow -37.7m)
EPS Correlation: 71.90 | EPS CAGR: 17.44% | SUE: 4.0 | # QB: 1
Revenue Correlation: -62.03 | Revenue CAGR: -28.12% | SUE: -0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.08 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.30 | Chg30d=+0.005 | Revisions Net=+1 | Growth EPS=+0.0% | Growth Revenue=+602.2%